OTC Markets EXMKT - Delayed Quote USD

eFFECTOR Therapeutics, Inc. (EFTR)

Compare
0.0002 0.0000 (0.00%)
As of December 19 at 3:00:00 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
42,000.0000
Operating Expense
32,704.0000
33,844.0000
32,403.0000
31,897.0000
26,181.0000
Operating Income
-32,704.0000
-33,844.0000
-32,403.0000
-31,897.0000
15,819.0000
Net Non Operating Interest Income Expense
-1,910.0000
-1,947.0000
-1,812.0000
-1,758.0000
-1,266.0000
Other Income Expense
-17.0000
-20.0000
11,550.0000
49,453.0000
9.0000
Pretax Income
-34,631.0000
-35,811.0000
-22,665.0000
15,798.0000
14,562.0000
Tax Provision
--
--
--
--
351.0000
Net Income Common Stockholders
-34,631.0000
-35,811.0000
-22,665.0000
15,798.0000
166.0000
Average Dilution Earnings
--
--
--
--
133.0000
Diluted NI Available to Com Stockholders
-34,631.0000
-35,811.0000
-22,665.0000
15,798.0000
299.0000
Basic EPS
-12.57
-16.37
-13.76
26.25
0.10
Diluted EPS
-12.57
-16.37
-13.76
11.00
0.10
Basic Average Shares
2,787.3410
2,186.9540
1,647.1830
604.2340
1,614.7740
Diluted Average Shares
2,787.3410
2,186.9540
1,647.1830
1,440.1620
1,614.7740
Total Operating Income as Reported
-32,704.0000
-33,844.0000
-32,403.0000
-31,897.0000
15,819.0000
Total Expenses
32,704.0000
33,844.0000
32,403.0000
31,897.0000
26,181.0000
Net Income from Continuing & Discontinued Operation
-34,631.0000
-35,811.0000
-22,665.0000
15,798.0000
14,211.0000
Normalized Income
-34,637.0000
-35,817.0000
-34,789.0000
-19,547.1400
14,211.0000
Interest Income
1,069.0000
972.0000
439.0000
6.0000
67.0000
Interest Expense
2,979.0000
2,919.0000
2,251.0000
1,764.0000
1,333.0000
Net Interest Income
-1,910.0000
-1,947.0000
-1,812.0000
-1,758.0000
-1,266.0000
EBIT
-31,652.0000
-32,892.0000
-20,414.0000
17,562.0000
15,895.0000
EBITDA
-31,541.0000
-32,781.0000
-20,361.0000
17,586.0000
16,055.0000
Reconciled Depreciation
111.0000
111.0000
53.0000
24.0000
160.0000
Net Income from Continuing Operation Net Minority Interest
-34,631.0000
-35,811.0000
-22,665.0000
15,798.0000
14,211.0000
Total Unusual Items Excluding Goodwill
6.0000
6.0000
12,124.0000
48,418.0000
--
Total Unusual Items
6.0000
6.0000
12,124.0000
48,418.0000
--
Normalized EBITDA
-31,547.0000
-32,787.0000
-32,485.0000
-30,832.0000
16,055.0000
Tax Rate for Calcs
--
--
--
0.0003
0.0000
Tax Effect of Unusual Items
--
--
--
13,072.8600
--
12/31/2020 - 8/27/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EMBT Ember Therapeutics, Inc.
0.0001
0.00%
 
INNMF Amplia Therapeutics Limited
0.0550
-21.43%
 
2696.HK Shanghai Henlius Biotech, Inc.
23.900
+0.21%
 
KRBP Kiromic BioPharma, Inc.
1.1000
+19.57%
 
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
 
MLEC Moolec Science SA
0.8600
0.00%
 
UPB Upstream Bio, Inc.
16.47
-0.84%
 
ANL Adlai Nortye Ltd.
2.1146
-5.60%
 
RNXT RenovoRx, Inc.
1.1757
+2.23%
 
VINC Vincerx Pharma, Inc.
0.2038
-1.45%